Answers are grounded in this paper and cite their sources.
Methotrexate-induced epidermal necrosis is a rare, potentially fatal cutaneous reaction that can be difficult to distinguish clinically from Stevens–Johnson syndrome and toxic epidermal necrolysis. Risk factors for methotrexate-induced necrolysis include renal insufficiency, older age, and high doses of methotrexate without folic acid. Early signs of methotrexate-induced necrolysis include painful skin erosions, mucocutaneous ulcerations, thrombocytopenia, and leukopenia. Diagnostic accuracy is essential when differentiating between these entities, as methotrexate discontinuation and leucovorin rescue is the first-line treatment for methotrexate-induced necrolysis, whereas systemic immunosuppressants are used for Stevens–Johnson syndrome. The case herein presents a rare report of methotrexate-induced necrolysis in a patient with chronic kidney disease.
No takes yet. Share an insight, caveat, or question.
A 2025 study studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: